Skip to content
← All startups
Xanadu Bio logo

Xanadu Bio

Series B

Delivery of nanoparticle system for mRNA and other payload delivery. The company leverages poly amine-co-esters(PACE) technology for efficient delivery of and protection from nuclease degradation for different types of nucleic acids, including mRNA targeting infectious diseases, such as COVID-19.

Life Sciences · Drug Delivery · United States · EST 2021

About

Delivery of nanoparticle system for mRNA and other payload delivery. The company leverages poly amine-co-esters(PACE) technology for efficient delivery of and protection from nuclease degradation for different types of nucleic acids, including mRNA targeting infectious diseases, such as COVID-19.

Latest coverage

📰 See all funding news — keep up with the raises that set comps.

Investor directory

🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.

Raising like Xanadu Bio?

Analyze your pitch deck before your next raise.

Analyze My Deck →